No. of unnecessary antibiotic prescriptions
No. of unnecessary antibiotic prescriptions
Company
What's New
MeMed BV
MeMed Key
Pipeline
Evidence
Support
AMR
More
Press Releases
Press Releases
DiaSorin and MeMed Partner to Develop and Commercialize Novel Host Immune Response Based Diagnostic Solution
September 8, 2020
Prospective Study Finds Potential Utility of MeMed's Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients
July 23, 2020
MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform
June 2, 2020
MeMed Advances Diagnostic Solutions for COVID-19 Pandemic to Enable Enhanced Patient Management
May 25, 2020
Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer
Oct 29, 2019
